Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes

globenewswire

Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes – NEWSnet – News… as it used to be

More Press Releases

May 1, 2026

Elite Sports Releases Color BJJ Gis with Pre-Shrunk, Pearl-Weave Fabric for Long-Term Use

May 1, 2026

Maivest Digital Capital Inc.: Building a New Generation of Intelligent Investment Platform Through Technology

May 1, 2026

Is Backpack Armor Really Safe? A Parent’s Guide to What Actually Matters

May 1, 2026

Biosplice Therapeutics Announces First Patient Dosed in NCI-Sponsored Clinical Trial of Cirtuvivint in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Elite Sports Releases Color BJJ Gis with Pre-Shrunk, Pearl-Weave Fabric for Long-Term Use

Maivest Digital Capital Inc.: Building a New Generation of Intelligent Investment Platform Through Technology

Is Backpack Armor Really Safe? A Parent’s Guide to What Actually Matters

Kleinschmidt Associates Welcomes Maciej (Mac) Lambrych as Quality Management Systems Manager